Page last updated: 2024-08-18

pyrroles and Antibody Deficiency Syndrome

pyrroles has been researched along with Antibody Deficiency Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abinun, M; Allenspach, EJ; Castro-Wagner, J; Cooper, MA; Cunningham-Rundles, C; Demirdag, YY; Eckstein, O; Forbes, LR; Freeman, AF; Gennery, A; Guillerman, RP; Holland, SM; Leiding, JW; Lilic, D; Milner, JD; Olbrich, P; Patel, NC; Plant, AS; Schussler, E; Slatter, M; Su, HC; Szabolcs, P; Torgerson, TR; Vogel, TP; Weinacht, KG; Zerbe, C	1

Other Studies

1 other study(ies) available for pyrroles and Antibody Deficiency Syndrome

Article	Year
Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations. The Journal of allergy and clinical immunology, 2018, Volume: 142, Issue:5 Topics: Adolescent; Adult; Child; Female; Gain of Function Mutation; Humans; Immunologic Deficiency Syndromes; Janus Kinases; Male; Nitriles; Piperidines; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Pyrroles; STAT1 Transcription Factor; STAT3 Transcription Factor; Treatment Outcome	2018

Article

Year

Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations.

The Journal of allergy and clinical immunology, 2018, Volume: 142, Issue:5

Topics: Adolescent; Adult; Child; Female; Gain of Function Mutation; Humans; Immunologic Deficiency Syndromes; Janus Kinases; Male; Nitriles; Piperidines; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Pyrroles; STAT1 Transcription Factor; STAT3 Transcription Factor; Treatment Outcome

2018